V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20206640 | 20077281 | null | 82 | Neo-adjuvant (N) | 2019-09-21 | 2019-10-06 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100647816 |
| 20206641 | 20077282 | 1.7 | null | Neo-adjuvant (N) | 2018-01-29 | 2018-02-02 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101714563 |
| 20206643 | 20077283 | 1.91 | 99.9 | 03 | 2021-10-11 | 2021-10-25 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 100620310 |
| 20206645 | 20077284 | 1.81 | 78 | null | 2017-10-16 | 2017-10-20 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 101395606 |
| 20206646 | 20077285 | 1.68 | 54 | null | 2019-02-01 | 2019-02-15 | Capecitabine (21days) + Carboplatin | 02 | null | CAPECITABINE + CARBOPLATIN | 101222512 |
| 20206652 | 20077286 | 1.79 | 70.3 | Palliative (P) | 2017-09-29 | 2017-10-12 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100164739 |
| 20206653 | 20077287 | 1.62 | 66 | Neo-adjuvant (N) | 2017-06-04 | 2017-06-16 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100079137 |
| 20206655 | 20077288 | 1.76 | 80.6 | Palliative (P) | 2017-02-18 | 2017-03-05 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101674133 |
| 20206658 | 20077289 | 1.6 | 86.7 | Neo-adjuvant (N) | 2016-07-25 | 2016-08-02 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101718405 |
| 20206663 | 20077290 | 1.78 | 128.5 | null | 2018-04-08 | 2018-04-08 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100734616 |
| 20206664 | 20077291 | 1.56 | 48.8 | Curative (C) | 2017-03-28 | 2017-04-19 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100668915 |
| 20206666 | 20077292 | 1.58 | 70.7 | Neo-adjuvant (N) | 2017-06-08 | 2017-06-08 | Capecitabine (21days) + Carboplatin | 02 | N | CISPLATIN + FLUOROURACIL | 101628595 |
| 20206668 | 20077293 | 1.62 | 75.2 | Adjuvant (A) | 2019-10-04 | 2019-10-10 | Capecitabine (21days) + Carboplatin | 02 | Y | CAPECITABINE + CARBOPLATIN | 101779077 |
| 20206670 | 20077294 | 1.77 | 67 | null | 2020-04-26 | 2020-05-03 | CAPECITABINE + CARBOPLATIN | 02 | null | CAPECITABINE + CARBOPLATIN | 100085098 |
| 20206671 | 20077295 | null | 107.2 | Palliative (P) | 2018-06-28 | 2018-07-05 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100292885 |
| 20206672 | 20077296 | 1.54 | 69 | Curative (C) | 2017-02-03 | 2017-03-04 | Trial Unspecified | 01 | Y | TRIAL UNSPECIFIED | 100990160 |
| 20206673 | 20077297 | 1.68 | 92.1 | Neo-adjuvant (N) | 2017-04-14 | 2017-04-26 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100057003 |
| 20206674 | 20077298 | 1.63 | 65.5 | Neo-adjuvant (N) | 2017-06-20 | 2017-06-20 | CISPLATIN + FLUOROURACIL | N | N | CISPLATIN + FLUOROURACIL | 101819019 |
| 20206675 | 20077299 | 1.58 | 64.2 | Palliative (P) | 2017-10-05 | 2017-10-20 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101688821 |
| 20206676 | 20077300 | 0 | 0 | null | 2019-01-21 | 2019-02-13 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 100213754 |
| 20206677 | 20077301 | 1.7 | 93.5 | null | null | 2016-12-29 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 100579882 |
| 20206679 | 20077302 | 1.57 | 90.6 | Neo-adjuvant (N) | 2016-12-25 | 2016-12-31 | CISPLATIN + FLUOROURACIL | N | N | CISPLATIN + FLUOROURACIL | 101061275 |
| 20206685 | 20077303 | 1.63 | 76.1 | Palliative (P) | 2017-04-15 | 2017-04-29 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100805814 |
| 20206688 | 20077304 | null | 59.7 | Palliative (P) | 2018-10-28 | 2018-11-18 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100654979 |
| 20206690 | 20077305 | 1.73 | 42 | Adjuvant (A) | 2017-11-28 | 2017-12-01 | Cisplatin +Fluorouracil (3 wk) | 02 | null | CISPLATIN + FLUOROURACIL | 100096963 |
| 20206691 | 20077306 | 1.72 | 90.5 | Curative (C) | 2017-11-01 | 2017-11-15 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100793509 |
| 20206694 | 20077307 | 1.58 | 64.8 | Curative (C) | 2019-09-28 | 2019-09-28 | Trial Unspecified | 01 | Y | TRIAL UNSPECIFIED | 101009805 |
| 20206696 | 20077308 | 1.6 | 79.4 | Palliative (P) | 2018-11-20 | 2018-12-11 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101767418 |
| 20206697 | 20077309 | 1.67 | 82.5 | Neo-adjuvant (N) | 2018-10-30 | 2018-11-04 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100317050 |
| 20206700 | 20077310 | 0.97 | 90.9 | Palliative (P) | 2017-05-06 | 2017-05-06 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100631622 |
| 20206701 | 20077311 | 1.76 | 103 | Palliative (P) | 2018-10-09 | 2018-10-15 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 101490881 |
| 20206703 | 20077312 | 1.78 | 76.6 | Curative (C) | 2018-01-14 | 2018-01-21 | Cisplatin +Fluorouracil (3 wk) | 02 | Y | CISPLATIN + FLUOROURACIL | 101551963 |
| 20206704 | 20077313 | 0 | 0 | Adjuvant (A) | 2017-06-23 | 2017-06-23 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100661560 |
| 20206707 | 20077314 | 1.65 | 88 | Curative (C) | 2017-05-10 | 2017-05-10 | Trial Unspecified | 02 | Y | TRIAL UNSPECIFIED | 100956125 |
| 20206709 | 20077315 | 1.85 | 87.4 | Neo-adjuvant (N) | 2019-10-25 | 2019-11-09 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100646974 |
| 20206710 | 20077316 | 1.49 | 92.3 | Palliative (P) | 2018-02-03 | 2018-02-28 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100624767 |
| 20206713 | 20077317 | 0 | 0 | Palliative (P) | 2016-09-21 | 2016-10-16 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 101762552 |
| 20206714 | 20077318 | 1.64 | 86 | Palliative (P) | 2016-05-11 | 2016-06-01 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100955717 |
| 20206715 | 20077319 | 1.72 | 64.9 | 03 | 2017-12-29 | 2018-01-08 | CISPLATIN + FLUOROURACIL + RT | N | N | CISPLATIN + FLUOROURACIL | 100523921 |
| 20206717 | 20077320 | 1.6 | 141 | 01 | 2019-08-30 | 2019-09-05 | Capecitabine (21days) + Carboplatin | N | N | CISPLATIN + FLUOROURACIL | 101267020 |
| 20206718 | 20077321 | null | 62.55 | Palliative (P) | 2018-02-13 | 2018-02-20 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101510776 |
| 20206719 | 20077322 | 1.77 | 103 | Palliative (P) | 2017-12-30 | 2017-12-30 | Capecitabine (21days) + Carboplatin | N | N | TRIAL UNSPECIFIED | 100004760 |
| 20206721 | 20077323 | 1.78 | 48.7 | 03 | 2016-03-12 | 2016-03-21 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 100343293 |
| 20206724 | 20077324 | 0 | 0 | Curative (C) | 2016-10-03 | 2016-10-11 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 101292995 |
| 20206727 | 20077325 | 1.56 | 79.2 | Palliative (P) | 2017-05-23 | 2017-06-13 | CAPECITABINE + CARBOPLATIN | 02 | Y | CAPECITABINE + CARBOPLATIN | 100822131 |
| 20206735 | 20077326 | 1.74 | 85 | Neo-adjuvant (N) | 2019-10-13 | 2019-10-28 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 101669887 |
| 20206738 | 20077327 | 1.7 | 69.05 | Neo-adjuvant (N) | 2016-09-12 | 2016-09-26 | Cisplatin +Fluorouracil (3 wk) | null | N | CISPLATIN + FLUOROURACIL | 101112888 |
| 20206739 | 20077328 | 1.81 | 82.4 | Neo-adjuvant (N) | 2017-11-27 | 2017-12-04 | CAPECITABINE + CARBOPLATIN | 02 | null | CAPECITABINE + CARBOPLATIN | 100829551 |
| 20206740 | 20077329 | 1.67 | 71.65 | Curative (C) | 2019-12-07 | 2019-12-21 | Doxorubicin chemoembolisation | 99 | null | DOXORUBICIN EMBOLISATION | 101713991 |
| 20206741 | 20077330 | 1.8 | 86.6 | Disease modification (D) | 2019-06-16 | 2019-06-16 | Capecitabine (21days) + Carboplatin | 02 | N | CISPLATIN + FLUOROURACIL | 101678322 |